These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29904327)

  • 21. User Experiences of Prescription and Over-The-Counter Drug Abuse in Aden City, Yemen.
    Abood EA; Scott J; Wazaify M
    Pharmacy (Basel); 2018 Sep; 6(3):. PubMed ID: 30217022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance and uncertainty: community pharmacy responses to over the counter medicine abuse.
    Cooper R
    Health Soc Care Community; 2013 May; 21(3):254-62. PubMed ID: 23320510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gabapentin and pregabalin: abuse and addiction.
    Prescrire Int; 2012 Jun; 21(128):152-4. PubMed ID: 22822593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abuse and Misuse of Prescription and Nonprescription Drugs from Community Pharmacies in Aden City-Yemen.
    Abood EA; Wazaify M
    Subst Use Misuse; 2016 Jun; 51(7):942-7. PubMed ID: 27100671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pregabalin--a drug with abuse potential?].
    Skopp G; Zimmer G
    Arch Kriminol; 2012; 229(1-2):44-54. PubMed ID: 22448469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On the risk of dependence on gabapentinoids].
    Bonnet U; Scherbaum N
    Fortschr Neurol Psychiatr; 2018 Feb; 86(2):82-105. PubMed ID: 29179227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database.
    Asomaning K; Abramsky S; Liu Q; Zhou X; Sobel RE; Watt S
    Int J Clin Pract; 2016 May; 70(5):380-8. PubMed ID: 27028939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential for pregabalin abuse or diversion after past drug-seeking behavior.
    Filipetto FA; Zipp CP; Coren JS
    J Am Osteopath Assoc; 2010 Oct; 110(10):605-7. PubMed ID: 21068226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregabalin Abuse amongst Opioid Substitution Treatment Patients.
    McNamara S; Stokes S; Kilduff R; Shine A
    Ir Med J; 2015; 108(10):309-10. PubMed ID: 26817289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qualitative exploration of the experiences of men who use drugs of obtaining psychoactive medicinal products in Jordan.
    Wazaify M; Alhusein N; Scott J
    J Ethn Subst Abuse; 2020 Oct; ():1-17. PubMed ID: 33121396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Codeine Is My Helper": Misuse of and Dependence on Codeine-Containing Medicines in South Africa.
    Van Hout MC; Rich E; Dada S; Bergin M
    Qual Health Res; 2017 Feb; 27(3):341-350. PubMed ID: 26582195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history.
    Driot D; Chicoulaa B; Jouanjus E; Dupouy J; Oustric S; Lapeyre-Mestre M
    Therapie; 2016 Dec; 71(6):575-578. PubMed ID: 27473599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gabapentin and pregabalin: do the benefits outweigh the harms?
    Morrison EE; Sandilands EA; Webb DJ
    J R Coll Physicians Edinb; 2017 Dec; 47(4):310-313. PubMed ID: 29537399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowledge, Attitudes, and Beliefs Regarding Drug Abuse and Misuse among Community Pharmacists in Saudi Arabia.
    Mobrad AM; Alghadeer S; Syed W; Al-Arifi MN; Azher A; Almetawazi MS; Babelghaith SD
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32092993
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.
    Darbà J; Kaskens L; Pérez C; Álvarez E; Navarro-Artieda R; Sicras-Mainar A
    Adv Ther; 2014 Jan; 31(1):1-29. PubMed ID: 24390901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.
    Chiappini S; Schifano F
    CNS Drugs; 2016 Jul; 30(7):647-54. PubMed ID: 27312320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregabalin abuse for enhancing sexual performance: case discussion and literature review.
    Osman M; Casey P
    Ir J Psychol Med; 2014 Dec; 31(4):281-286. PubMed ID: 30189505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregabalin's abuse potential: a mini review focusing on the pharmacological profile.
    Papazisis G; Tzachanis D
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):709-16. PubMed ID: 24849194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug abuse of pregabalin - state of the situation, risks and means of control].
    Laribi M; Chaouali N; Jaballah S; Amira D; Hedhili A
    Ann Pharm Fr; 2023 May; 81(3):419-424. PubMed ID: 36375531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.